GlassScriptPhysician profile
Robert G Dorfman
NPI 1013308774
$5,226.63
in general payments reported to CMS, 2019-2025
6 companies · $3,333 in 2025
The $3,333 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $227 · 2023: $256 · 2024: $1,411 · 2025: $3,333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,610 · Food and Beverage: $2,390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,610.00 |
| Food and Beverage | $2,389.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $3,066.63 | 2023-2025 | Xeomin |
| Revance Therapeutics, INC. | $1,650.28 | 2024-2025 | Daxxify |
| Solta Medical, A Division of Bausch Health US, LLC | $243.74 | 2024-2025 | Clear & Brilliant |
| Allergan, INC. | $206.66 | 2022 | |
| Aroa Biosurgery Incorporated | $39.10 | 2023 | |
| Integra Lifesciences Corporation | $20.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dorfman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.